{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T12:57:27Z","timestamp":1781701047850,"version":"3.54.5"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22374155"],"award-info":[{"award-number":["22374155"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22327901"],"award-info":[{"award-number":["22327901"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81602946"],"award-info":[{"award-number":["81602946"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["XDB0540000"],"award-info":[{"award-number":["XDB0540000"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bcp.2026.117674","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:11:02Z","timestamp":1767658262000},"page":"117674","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Development of 6-methyl-4,5-dihydropyrazolo[3,4-d]pyrimidin-4-one derivatives as lead sigma-1 receptor inhibitor: synthesis and biological evaluation via MSI"],"prefix":"10.1016","volume":"245","author":[{"given":"Peng-cheng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-huang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bcp.2026.117674_b0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41572-023-00484-9","article-title":"Central neuropathic pain","volume":"9","author":"Rosner","year":"2023","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"10289","key":"10.1016\/j.bcp.2026.117674_b0010","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1016\/S0140-6736(21)00392-5","article-title":"Nociplastic pain: towards an understanding of prevalent pain conditions","volume":"397","author":"Fitzcharles","year":"2021","journal-title":"Lancet (London, England)"},{"issue":"4","key":"10.1016\/j.bcp.2026.117674_b0015","first-page":"199","article-title":"Pain-resolving immune mechanisms in neuropathic pain","volume":"19","author":"Fiore","year":"2023","journal-title":"Nat. Rev. Neurol."},{"issue":"2","key":"10.1016\/j.bcp.2026.117674_b0020","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet. Neurol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117674_b0025","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1152\/physrev.00045.2019","article-title":"Neuropathic pain: from mechanisms to treatment","volume":"101","author":"Finnerup","year":"2021","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bcp.2026.117674_b0030","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev-pharmtox-010818-021524","article-title":"Neuropathic pain: mechanism-based therapeutics","volume":"60","author":"Bannister","year":"2020","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"11","key":"10.1016\/j.bcp.2026.117674_b0035","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1038\/s41386-023-01645-w","article-title":"Tianeptine promotes lasting antiallodynic effects in a mouse model of neuropathic pain","volume":"48","author":"Serafini","year":"2023","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.bcp.2026.117674_b0040","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/j.pain.0000000000002391","article-title":"Mitochondrial calcium uniporter deletion prevents painful diabetic neuropathy by restoring mitochondrial morphology and dynamics","volume":"163","author":"George","year":"2022","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.bcp.2026.117674_b0045","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221244","article-title":"Targeting neuroinflammation in neuropathic pain and opioid use","volume":"220","author":"Salvemini","year":"2023","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.bcp.2026.117674_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpainsymman.2012.10.230","article-title":"The evidence for pharmacologic treatment of neuropathic cancer pain: beneficial and adverse effects","volume":"46","author":"Jongen","year":"2013","journal-title":"J. Pain Symptom Manage."},{"issue":"24","key":"10.1016\/j.bcp.2026.117674_b0055","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1016\/j.cell.2023.10.029","article-title":"Molecular basis of opioid receptor signaling","volume":"186","author":"Che","year":"2023","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bcp.2026.117674_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2022.12.026","article-title":"Structures of the entire human opioid receptor family","volume":"186","author":"Wang","year":"2023","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.bcp.2026.117674_b0065","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1001\/jamasurg.2023.2009","article-title":"Association of intraoperative opioid administration with postoperative pain and opioid use","volume":"158","author":"Santa Cruz Mercado","year":"2023","journal-title":"JAMA Surg."},{"issue":"2","key":"10.1016\/j.bcp.2026.117674_b0070","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/jamapsychiatry.2020.3554","article-title":"Prescription opioid use and risk for major depressive disorder and anxiety and stress-related disorders: a multivariable mendelian randomization analysis","volume":"78","author":"Rosoff","year":"2021","journal-title":"JAMA Psychiat."},{"key":"10.1016\/j.bcp.2026.117674_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100321","article-title":"The epidemiology of regular opioid use and its association with mortality: prospective cohort study of 466 486 UK biobank participants","volume":"21","author":"Macfarlane","year":"2020","journal-title":"EClinicalMedicine"},{"issue":"3","key":"10.1016\/j.bcp.2026.117674_b0080","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0022-3565(25)30536-7","article-title":"The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog","volume":"197","author":"Martin","year":"1976","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"20","key":"10.1016\/j.bcp.2026.117674_b0085","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.2174\/0929867033456783","article-title":"Understanding the molecular mechanism of sigma-1 receptors: towards a hypothesis that sigma-1 receptors are intracellular amplifiers for signal transduction","volume":"10","author":"Su","year":"2003","journal-title":"Curr. Med. Chem."},{"issue":"7600","key":"10.1016\/j.bcp.2026.117674_b0090","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nature17391","article-title":"Crystal structure of the human sigma1 receptor","volume":"532","author":"Schmidt","year":"2016","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bcp.2026.117674_b0095","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0014-2999(90)90186-A","article-title":"N-methyl-D-aspartate-induced neuronal activation is selectively modulated by sigma receptors","volume":"179","author":"Monnet","year":"1990","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117674_b0100","doi-asserted-by":"crossref","first-page":"R5","DOI":"10.1016\/S0014-2999(97)01064-9","article-title":"Enhanced kappa-opioid receptor-mediated analgesia by antisense targeting the sigma1 receptor","volume":"331","author":"King","year":"1997","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2026.117674_b0105","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2174\/157015908787386113","article-title":"Pharmacology and therapeutic potential of sigma(1) receptor ligands","volume":"6","author":"Cobos","year":"2008","journal-title":"Curr. Neuropharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2026.117674_b0110","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1124\/mol.109.057083","article-title":"Sigma 1 receptor modulation of G-protein-coupled receptor signaling: potentiation of opioid transduction independent from receptor binding","volume":"77","author":"Kim","year":"2010","journal-title":"Mol. Pharmacol."},{"issue":"10","key":"10.1016\/j.bcp.2026.117674_b0115","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/s41594-018-0137-2","article-title":"Structural basis for sigma(1) receptor ligand recognition","volume":"25","author":"Schmidt","year":"2018","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117674_b0120","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejphar.2005.01.036","article-title":"Formalin-induced pain is reduced in sigma(1) receptor knockout mice","volume":"511","author":"Cendan","year":"2005","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117674_b0125","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1021\/acs.jmedchem.7b01584","article-title":"(+)-Methyl (1R,2S)-2-[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]methyl-1-phenylcyclopropanecarboxylate [(+)-MR200] derivatives as potent and selective sigma receptor ligands: stereochemistry and pharmacological properties","volume":"61","author":"Amata","year":"2018","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bcp.2026.117674_b0130","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1021\/jm3017893","article-title":"Design and synthesis of new bifunctional sigma-1 selective ligands with antioxidant activity","volume":"56","author":"Prezzavento","year":"2013","journal-title":"J. Med. Chem."},{"issue":"24","key":"10.1016\/j.bcp.2026.117674_b0135","doi-asserted-by":"crossref","first-page":"10404","DOI":"10.1021\/jm501207r","article-title":"Synthesis and biological evaluation of novel sigma-1 receptor antagonists based on pyrimidine scaffold as agents for treating neuropathic pain","volume":"57","author":"Lan","year":"2014","journal-title":"J. Med. Chem."},{"issue":"15","key":"10.1016\/j.bcp.2026.117674_b0140","doi-asserted-by":"crossref","first-page":"5881","DOI":"10.1021\/jm100116p","article-title":"Synthesis and resolution of cis-(+\/-)-methyl (1R,2S\/1S,2R)-2-[(4-hydroxy-4-phenylpiperidin-1-yl)methyl]-1-(4-methylphenyl)cyclopropanecarboxylate [(+\/-)-PPCC)]: new sigma receptor ligands with neuroprotective effect","volume":"53","author":"Prezzavento","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2026.117674_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.128860","article-title":"Design, synthesis and biological evaluation of novel aminopropylcarboxamide derivatives as sigma ligands","volume":"72","author":"Zampieri","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bcp.2026.117674_b0150","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ejmech.2014.04.019","article-title":"Synthesis and biological evaluation of a novel sigma-1 receptor antagonist based on 3,4-dihydro-2(1H)-quinolinone scaffold as a potential analgesic","volume":"79","author":"Lan","year":"2014","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bcp.2026.117674_b0155","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.bmcl.2016.02.077","article-title":"Synthesis and biological evaluation of novel 6,7-dihydro-5H-cyclopenta[d]pyrimidine and 5,6,7,8-tetrahydroquinazoline derivatives as sigma-1 (sigma1) receptor antagonists for the treatment of pain","volume":"26","author":"Lan","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"7","key":"10.1016\/j.bcp.2026.117674_b0160","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1021\/acs.jmedchem.5b01416","article-title":"Synthesis and Biological Evaluation of Novel sigma1 Receptor Ligands for Treating Neuropathic Pain: 6-Hydroxypyridazinones","volume":"59","author":"Cao","year":"2016","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bcp.2026.117674_b0165","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.apsb.2019.07.002","article-title":"Novel radioligands for imaging sigma-1 receptor in brain using positron emission tomography (PET)","volume":"9","author":"Lan","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"issue":"4","key":"10.1016\/j.bcp.2026.117674_b0170","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0922-4106(92)90153-M","article-title":"Characterization of the binding of [3H](+)-pentazocine to sigma recognition sites in guinea pig brain","volume":"227","author":"DeHaven-Hudkins","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2026.117674_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112426","article-title":"Azithromycin regulates Mettl3-mediated NF-\u03baB pathway to enhance M2 polarization of RAW264.7 macrophages and attenuate LPS-triggered cytotoxicity of MLE-12 alveolar cells","volume":"137","author":"Xu","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bcp.2026.117674_b0180","doi-asserted-by":"crossref","first-page":"927","DOI":"10.2174\/138955705774329519","article-title":"Pharmacofore identification for sigma-1 (sigma1) receptor binding: applications of the \u201cdeconstruction-reconstruction-elaboration\u201d approach","volume":"5","author":"Glennon","year":"2009","journal-title":"Mini Rev. Med. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2026.117674_b0185","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1021\/acs.jmedchem.0c01964","article-title":"Novel sigma 1 receptor antagonists as potential therapeutics for pain management","volume":"64","author":"Peng","year":"2021","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2026.117674_b0190","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1039\/D0MD00186D","article-title":"In vitro and in vivo sigma 1 receptor imaging studies in different disease states","volume":"12","author":"Agha","year":"2020","journal-title":"RSC Med. Chem."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226000055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226000055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T12:13:49Z","timestamp":1781698429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226000055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":38,"alternative-id":["S0006295226000055"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117674","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of 6-methyl-4,5-dihydropyrazolo[3,4-d]pyrimidin-4-one derivatives as lead sigma-1 receptor inhibitor: synthesis and biological evaluation via MSI","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117674","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117674"}}